|
Quotes & Info
|
| CRXX > SEC Filings for CRXX > Form 8-K on 3-Jun-2009 | All Recent SEC Filings |
3-Jun-2009
Other Events, Financial Statements and Exhibits
On June 3, 2009, CombinatoRx, Incorporated ("CombinatoRx") issued a press release announcing positive results from a Phase 1 bioavailability study of SynaviveTM (CRx-102). The full text of CombinatoRx's press release regarding the announcement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
(d) Exhibits
Exhibit No. Description
99.1 Press release of CombinatoRx, Incorporated dated June 3, 2009.
|
|